Module 2: Deprescribing Communication Techniques
Drive to Deprescribe: Learn how to engage PALTC residents and their families in effective conversations about medication deprescribing with this 30-minute, interactive course.
Read MoreShowing 91 - 100 of 228 results
Drive to Deprescribe: Learn how to engage PALTC residents and their families in effective conversations about medication deprescribing with this 30-minute, interactive course.
Read MoreThe Mountain West PALTC Annual Meeting is set for May 1st and promises to be an exciting and enriching event. This one-day conference will feature a line up of amazing and diverse speakers who will share their insights and expertise on various topics relevant to Post Acute and Long-term Care. Attendees can look forward to engaging discussions, networking opportunities, and valuable takeaways that can enhance their practices and improve care delivery.
Read MoreSpeaker: Scott Bolhack, MD, MBA, CMD, CWSP, FACP
Read MoreRamkota Hotel, Sioux Falls, SD
Read MoreThe NCSPALTC Annual Seminar is an educational event for medical professionals in the long term care setting to learn about changes in regulations, survey process, procedures and clinical topics to assist the professional in providing his/her care to your residents.
Read MoreJoin us for a live webinar June 24 at 12:00 PM EST and be among the first to learn about a newly approved treatment for Alzheimer’s disease! In collaboration with Alpha Cognition, this edition will educate on the differentiation of the newly approved treatment based on its underlying technology and mechanism of action, as well as review the treatment’s efficacy and safety established from clinical trials and real-world evidence. The speakers, including Michael McFadden, Chief Executive Officer at Alpha Cognition, will enable participants to explore unmet needs in the treatment of Alzheimer’s Disease and learn about a new treatment. Register now.
US-ZUNV-00069 V1
Join us for a live webinar July 29 at 12:00 PM EST and be among the first to learn about a newly approved treatment for Alzheimer’s disease! In collaboration with Alpha Cognition, this edition will educate on the differentiation of the newly approved treatment based on its underlying technology and mechanism of action, as well as review the treatment’s efficacy and safety established from clinical trials and real-world evidence. The speakers, including Michael McFadden, Chief Executive Officer at Alpha Cognition, will enable participants to explore unmet needs in the treatment of Alzheimer’s Disease and learn about a new treatment. Register now.
US-ZUNV-00069 V1
Earn CME/CMD/MOC credits while networking with colleagues in Post-Acute and Long Term Care.
Read More